课题基金 / 基金详情

AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN

AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN
氨基丙二酸和蛋白质的钙化
批准号:
3354958
负责人:
TAD H KOCH
金额:
$6.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 1989-11-30

项目摘要

项目成果

TAD H KOCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aminomalonic acid has been discovered in alkaline hydrolysates of bacterial protein, calcified human arterial proteins, and in calcified prosthetic devices fabricated from bovine pericardium. Based upon preliminary evidence, the formation of Ama residues in structural proteins is postulated to be involved in the pathological calcification of these proteins in diseases such atherosclerosis and in prosthetic devices such as artificial heart heart valves. More specifically the proposal states 1) that Ama residues in structural proteins are formed through the post-translational free radical carboxylation of Gly residues, 2) that Ama residues, most likely in clusters, serve as binding sites for calcium ions and consequently, nucleate calcium phosphate crystallization, 3) that the free radical carboxylations is initiated by radicals from decomposition of lipid hydroperoxides possibly those present in arterial fatty streaks which form prior to calcification or by radicals produced by stimulated phagocytes, and 4) that the calcification of prosthetic devices fabricated from bovine pericardium can be dramatically inhibited by blocking Ama formation through the chemical transformation of selected Gly residues to Ser residues. The specific studies which will be performed are 1) the synthesis of peptide units containing Ama residues which might logically be metal binding sites in protein, 2) the determination of the metal binding properties of these peptides, 3) the determination from model studies of the formation of Ama residues via free radical induced carboxylation of Gly residues of structural protein especially type 1 collagen of bovine percardium utilized to fabricate prosthetic devices, 4) the development of the method of free radical conversion of exposed Gly residues to Ser residues for the inhibition of pathological calcification of prosthetic devices, and 5) establishing that the inhibition is in fact related to the blocking of in vivo Ama formation. An important health related result will be the development of a process for the modification of bovine pericardium which will inhibit the in vivo, pathological calcification of prosthetic devices for human implant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma
  • 批准号:
    8307764
  • 项目类别:
  • 资助金额:
    $16.48万
  • 财政年份:
    2011
  • 负责人:
    TAD H KOCH
  • 依托单位:
Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma
  • 批准号:
    8184992
  • 项目类别:
  • 资助金额:
    $19.77万
  • 财政年份:
    2011
  • 负责人:
    TAD H KOCH
  • 依托单位:
Development of a CES 2-Activated Doxazolidine Prodrug for Pancreatic Cancer
  • 批准号:
    7707826
  • 项目类别:
  • 资助金额:
    $21.06万
  • 财政年份:
    2009
  • 负责人:
    TAD H KOCH
  • 依托单位:
New Drugs Targeted to Metastatic Cancer and Angiogenesis
  • 批准号:
    6634078
  • 项目类别:
  • 资助金额:
    $18.79万
  • 财政年份:
    2001
  • 负责人:
    TAD H KOCH
  • 依托单位:
海外基金